Spark Therapeutics
AcquiredGenentech
Philadelphia, United States · Founded 2013 · $72.8M raised
- Headquarters
- Philadelphia, Pennsylvania
- Employees
- 201–500
- Founded
- 2013
- Business Model
- B2B
- Website
- sparktx.com
- Total Funding
- $72.8M
- Last Round
- $72.8M Series BMay 2014
- Rounds
- 1
About
Spark Therapeutics develops gene therapy treatments for debilitating genetic diseases; acquired by Roche in 2019 and now a Roche subsidiary.
Summary
Spark Therapeutics is a Biotech company based in Philadelphia, United States, founded in 2013. It has raised $72.8M in total across 1 round, most recently a $72.8M Series B round in May 2014.
Tech & App Stack
4 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
May 2014
Similar Companies
Specialty pharmaceutical company focused on addressing therapeutic needs in the fields of psychia...
Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...
Abogen Biosciences develops RNA therapeutics using integrated mRNA design, lipid nanoparticle del...
Biopharmaceutical company developing and commercializing RNAi therapeutics to treat genetically d...
Clinical-stage programmable cell therapy company developing engineered T-cell therapies for solid...
Clinical-stage biotech developing next-generation CAR T-cell therapies for cancer patients aiming...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/spark-therapeutics"><img src="https://indexed.vc/api/badge/company/spark-therapeutics" alt="Spark Therapeutics on Indexed.vc" width="260" height="76" /></a>